OUR SUCCESSFUL STORY

NANOGEN BIOPHARMACEUTICAL is leading company that doing research and development of biopharmaceutical APIs, and specific therapeutic injections from recombinant DNA and protein technology in Asia Pacific region.

We are focus mainly on development of biopharmaceutical products from gene to therapy, serving high quality and innovative drug products for treatment of hepatitis B, hepatitis C, anemia due to chronic renal failure, myocardial infarction and cancer…

RECENT NEWS

Molecular and Cell Biology book award program 2014

For the first time, Nanogen Biopharmaceutical presented a Molecular and Cell Biology book award program to the representatives...

Nguồn lực kiều bào - Kỳ 2: Thuốc đặc trị cho người Việt

công trong sản xuất thuốc đặc trị tại VN, doanh nhân Việt kiều Mỹ, TS Hồ Nhân được...

OUR LATEST PRODUCTS

PEGSTAT

Peginterferon alfa 2b

Prefilled syringe, Lyophilized powder, Liquid vial.

Peginterferon alfa-2b  is a covalent conjugate of recombinant alfa-2b interferon with monomethoxy...

NANERCEPT

Etanercept

Prefilled syringe, Lyophilized powder, Liquid vial.

    Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding...

Hi-Tech Park considered good...

National Assembly Vice Chairwoman Nguyen Thi Kim Ngan said in her tour to the Hi-Tech Park in Ho...

CPhI Worldwide 2013 – Frankfurt,...

Well-known as an international interactive company in the biopharmaceutical market, Nanogen Biopharmaceutical...